<SEC-DOCUMENT>0001628280-22-004490.txt : 20220301
<SEC-HEADER>0001628280-22-004490.hdr.sgml : 20220301
<ACCEPTANCE-DATETIME>20220301160648
ACCESSION NUMBER:		0001628280-22-004490
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20220225
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220301
DATE AS OF CHANGE:		20220301

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Neoleukin Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001404644
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36327
		FILM NUMBER:		22697963

	BUSINESS ADDRESS:	
		STREET 1:		SUITE 360 - 1616 EASTLAKE AVE EAST
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98102
		BUSINESS PHONE:		206-732-2133

	MAIL ADDRESS:	
		STREET 1:		SUITE 360 - 1616 EASTLAKE AVE EAST
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98102

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AQUINOX PHARMACEUTICALS, INC
		DATE OF NAME CHANGE:	20140128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AQUINOX PHARMACEUTICALS (USA) INC
		DATE OF NAME CHANGE:	20070626
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>nltx-20220225.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:f1a7c94e-5dc0-46bc-9ae1-1be497247cfa,g:01524c8d-271b-4b1f-92b4-18746203b557,d:3390f78ef9b84922bb40a41c1fdf5ddb--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>nltx-20220225</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ic3c569ab422d47459eb842c2dd1f45d0_D20220225-20220225" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjMzOTBmNzhlZjliODQ5MjJiYjQwYTQxYzFmZGY1ZGRiL3NlYzozMzkwZjc4ZWY5Yjg0OTIyYmI0MGE0MWMxZmRmNWRkYl80L2ZyYWc6NjA2NWFlNWM0NjdlNDc0OGE0OGY2MWY0ZTBjMDFmYzYvdGFibGU6ZTJjMWE2ZTgwZWEzNGM3NDg3M2NiZGY5YzM0ZjQ1ZjcvdGFibGVyYW5nZTplMmMxYTZlODBlYTM0Yzc0ODczY2JkZjljMzRmNDVmN18yLTEtMS0xLTMwNzkw_60d43ca5-ab2f-4fa7-8bab-5c9cda8e1b29">0001404644</ix:nonNumeric><ix:nonNumeric contextRef="ic3c569ab422d47459eb842c2dd1f45d0_D20220225-20220225" nam